Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer. (nature.com)

Authors: Cai JY … Shao ZM Journal: Nature Communications Published: 2026-07-24 DOI: https://doi.org/10.1038/s41467-026-75386-x